Form 4: NeuroOne Medical Technologies Officer Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Steve Mertens, Chief Technology Officer of NeuroOne Medical Technologies, disposed of 252 shares of common stock on March 31, 2024, to cover tax obligations.
Summary
- On March 31, 2024, Steve Mertens, the Chief Technology Officer of NeuroOne Medical Technologies Corp, disposed of 252 shares of common stock.
- The transaction was executed to cover tax obligations at a price of $1.2 per share.
- Following the transaction, Mertens directly owns 183,911 shares of NeuroOne Medical Technologies Corp.
- The transaction was reported on April 2, 2024.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a routine transaction. It doesn't indicate positive or negative sentiment about the company's performance.
Industry Context
This is a routine disclosure related to insider transactions and is common for publicly traded companies. It provides transparency into the actions of company executives.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of transaction: Disposal of shares. |
| 04/02/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.